Dáil Éireann Debate, Tuesday - 20 June 2017
1075. Deputy Róisín Shortall asked the Minister for Health further to Parliamentary Question No. 962 of 2 May 2017, if he will request the HSE to circulate the international consensus primer for medical practitioners to all general practitioners to assist in the diagnosis of ME; and if he will make a statement on the matter. [26798/17]
View answer1076. Deputy Róisín Shortall asked the Minister for Health further to Parliamentary Question No. 962 of 2 May 2017, the reason the HSE has removed the section of their website on ME; if he will request the HSE to engage with a group (details supplied) to ensure the information that will be published is accurate and of use to those suffering with ME; and if he will make a statement on the matter. [26799/17]
View answer1077. Deputy Róisín Shortall asked the Minister for Health further to parliamentary question number 962 of 2 May 2017, if he will request the HSE to investigate the use and effectiveness of the drugs ampligen, rituximab and suramin to treat cohorts of persons with ME in other jurisdictions; if he will consider their use here; and if he will make a statement on the matter. [26800/17]
View answer1078. Deputy Róisín Shortall asked the Minister for Health further to Parliamentary Question No. 962 of 2 May 2017, if his attention has been drawn to the practices at a clinic (details supplied) in Sweden; if the HSE will examine the potential use of this multidisciplinary approach to diagnose and treat ME here; and if he will make a statement on the matter. [26801/17]
View answerI propose to take Questions Nos. 1075 to 1078, inclusive, together.
As these questions relate to the clinical diagnosis and management of ME as well as service issues, they are being referred to the HSE for direct reply.
